Catching Up In Pharmaceuticals: Government Policies and the Rise of Genomics
Author
Summary, in English
Genomics — the sequencing of the human genome and the identification of the genetic mechanisms of development and disease — is driving a restructuring of the global pharmaceutical industry. Many policy initiatives in biomedicine are based on the assumption that strength in genomics research will be translated into economic success, that is, that investments in genomics will be a way to catch up in the development of the bio-industries. There is therefore intense competition between nations and regions to establish a strong position in genomics, as shown in the growth of public expenditure on biomedical research in the last decade. This article addresses questions regarding the possibility of smaller countries catching up in the bio-based economy, given its present concentration within a few research-intensive networks and the historical advantage of established knowledge clusters, which exist primarily in the United States
Department/s
- Research Policy Institute (RPI)
Publishing year
2004
Language
English
Pages
161-170
Publication/Series
Australian Health Review
Volume
28
Issue
2
Document type
Journal article
Publisher
Australasian Medical Pub. Co. for the Australian Healthcare Association
Topic
- Social Sciences Interdisciplinary
Keywords
- International
- Genomics
- Studies
- Globalization
- Competition
- R&D
- Research & development
- Pharmaceutical industry
Status
Published
ISBN/ISSN/Other
- ISSN: 1449-8944